This collaboration is set to transform the Life Sciences sector by leveraging Deloitte’s expertise in process management, validation, onboarding, and consulting, alongside Flex Databases’ state-of-the-art electronic systems.
We’ve asked Luigi Visani, MD, President & CEO at Exom Group a couple of questions about the upcoming partnership:
Why did Exom Group decide to pick Flex Databases as a provider?
“Since its inception, Exom Group has adopted the most innovative digital solutions for clinical trial management, striving to keep systems up-to-date with new technological solutions as they become available. In addition, we must always adapt the many modules of our integrated Genius Suite platform to the continuous evolution of our needs. For this reason, after a careful and precise evaluation of the various solutions and providers on the market for CTMS and Pharmacovigilance, we have decided to choose Flex Databases as our new provider.”
What do you expect to achieve with the implementation of Flex Databases?
“Compared to previous solutions, we are confident that the implementation of Flex Databases will allow us to achieve a higher level of operational flexibility and technological unification. To support our operational processes and adapt them to the specific needs of each clinical trial, we need applications that are adaptable, easy to integrate, simple to use and stable, without of course forgetting security and regulatory compliance.
Flex Databases solutions meet these requirements and we are confident that they will help us in our daily effort to offer a service with high levels of quality and performance.”